Covaxin safe for children: Bharat Biotech

IMAGE: An Auxiliary Nurse Midwife healthcare worker inoculating a beneficiary with a dose of the COVID-19 vaccine during a door to door vaccination campaign at Margomunda, in Deoghar, Jharkhand,......

Bharat Biotech to make 900 million Covaxin vaccines

500 million doses per annum from its two sites in Hyderabad and 200 million doses each from its Ankleshwar and Kolar facilities.Sohini Das reports. IMAGE: Union Health Minister Harsh Vardhan shows......

Bharat Biotech's nasal Covid vaccine iNCOVACC launched

Union Health Minister Mansukh Mandaviya and Science and Technology Minister Jitendra Singh launched Bharat Biotech's nasal Covid vaccine, iNCOVACC, on the occasion of Republic Day on Thursday.......

Bharat Biotech has two more Covid vaccines in pipeline

Today, the firm has delivered over four billion doses of vaccines and has over 140 patents under its belt. The company has in its portfolio over 16 vaccines and four bio-therapeutics, including......

Bird flu: Bharat Biotech to develop vaccine

Close on the heels of Hetero Drugs launching Oseltamivir, an anti-bird flu drug, Nasdaq-listed Novavax Inc and Hyderabad-based Bharat Biotech International on Monday announced a strategic......

What's behind Bharat Biotech's Zika 'hype'?

Bharat Biotech started work on developing a vaccine against Zika way back in 2014, but the timing of its announcement has created a flutter in the market. When Bharat Biotech recently......

Bharat Biotech starts Covaxin's at-risk manufacture

The first vaccine candidate will be an intra-muscular one, followed by intra-dermal and nasal ones, depending on test results, reports Sohini Das. Photograph: Kind courtesy Bharat Biotech  ......

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs

India’s pharmaceuticals and medical devices industries are still hopeful that trade negotiations with the US could cut a fairer deal for both sides, after President Donald Trump announced a 25......